Evidence map›Paper›PMID 42338587›Full record

ReviewFrontiers in immunology2026

From thresholds to trajectories: a perspective on reframing alloimmune risk for computational modeling in solid organ transplantation.

Rajdeep Das, Reut Hod-Dvorai

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rajdeep DasDepartment of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
Reut Hod-DvoraiDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunological risk prediction in solid organ transplantation has long depended on threshold-based representation of histocompatibility data: donor-specific antibodies (DSA) reported as positive or negative, mean fluorescence intensity (MFI) assessed by fixed cutoffs, molecular mismatch assigned at transplantation, and assays interpreted at a single time point. Although practical, these conventions simplify the complex and dynamic nature of the immune response. In this perspective, we argue that as machine learning (ML) algorithms and computational approaches enter the field of transplant immunology, we need to focus on whether the inputs that feed into these tools and models reflect how alloimmunity actually behaves. We propose treating alloimmune risk as a time-indexed alloimmune state, updated whenever new data are available, across four domains: antibody profile, molecular mismatch and predicted immunogenicity, recipient immune context, and graft context. Within this framework, the features that experienced clinicians and histocompatibility experts already track (e.g., DSA velocity, persistence, epitope spreading, concordance with graft injury) become computable rather than implicit. We discuss how moving from thresholds to trajectories impacts model design, why HLA laboratory expertise becomes more important rather than less, and why interpretability, regulation, and external validation should precede clinical adoption.

Indexed as

Computer SimulationGraft RejectionModels, ImmunologicalOrgan TransplantationTransplantation ImmunologyAnimalsHistocompatibility TestingHLA AntigensHumansImmunoinformaticsIsoantibodiesMachine LearningSoft ComputingHLA AntigensIsoantibodiesalloimmune riskcomputational modelingHLAmachine learningsolid organ transplant

Identifiers

PMID42338587
PMCPMC13283783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.